President-elect Donald Trump announced his intent to nominate Robert F. Kennedy Jr. to lead the US Health and Human Services Department on 14 November, just one day after one of the US Food and Drug Administration’s top regulators warned the agency’s ability to approve innovative treatments could suffer under the leadership of an anti-vaccine activist like Kennedy.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?